ArchivesMagazine - 19 Jul 2018Grab a 6.2% yield with touchscreen engineer Zytronic Bullet-proof balance sheet limits downside and secures generous payout 19 July 2018|Great Ideas Issue: 19 Jul 2018 - Page 12 < Takeover activity means infrastructure funds are back in demand Recent investments should make Gear4Music a stronger business > Issue: 19 Jul 2018 - Page 12 | Contents Next: Recent investments should make Gear4Music a stronger business Previous: Takeover activity means infrastructure funds are back in demand Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Steven Frazer Issue Contents Editor's View Should all companies and funds be forced to broadcast AGMs online? Feature The big decision: take profits or run your winners? Funds Can a fund manager perform to the best of their abilities if they have to run multiple funds? Great Ideas Grab a 6.2% yield with touchscreen engineer Zytronic Recent investments should make Gear4Music a stronger business Great Ideas Update A £20m cash injection gives Marlowe power to do more deals DP Eurasia still tasty despite currency issues weighing on share price Accesso eyes festivals queue-busting opportunity Gamma Communications raises the bar again Investment Trusts Why it’s all about yield for Merchants Trust How refinancing debt could unlock more dividends and value for investment trusts Main Feature 10-year growth winners Money Matters New inheritance tax break could save you £140,000 – but how does it work? Should you stick with your auto-enrolment default fund? News Brexit rebellion averted Act now to take advantage of a superb buying opportunity in ASOS shares What do recruiters’ results tell us about the global economy? What investment trusts’ first half performance tells us about the markets Disappointing Chinese data inflates trade war fears Russ Mould How to respond to any potential sterling crisis Talking Point Takeover activity means infrastructure funds are back in demand Under The Bonnet Crunch time for Sirius Minerals as it tries to secure $3bn